Advances in Alzheimer’s Disease and Related Dementias
A special issue of NeuroSci (ISSN 2673-4087).
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 8328
Special Issue Editor
Interests: surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Alzheimer’s disease and related dementias remain the leading cause of death and disability worldwide. However, the current beta-amyloid (Aβ) and tau-targeting therapies for Alzheimer’s disease failed in the clinical trials, and whether Aβ accumulation is the cause or consequence of Alzheimer’s disease is unclear. Major advances have been made by investigating novel mechanisms underlying neuroinflammation, neuronal death, synaptic dysfunction, cerebrovascular dysfunction etc., which contribute to the development of Alzheimer’s disease and related dementias. The role of risk factors including aging, cardiovascular diseases, and metabolic disorders are also attracting attention by researchers to investigate the novel mechanisms underlying the pathogenesis of Alzheimer’s disease and related dementias. The present Special Issue aims to include research in all the areas related to studies in Alzheimer’s disease and related dementias. We invite manuscripts in the form of original research, reviews, mini-reviews, and short communications investigating/commenting on the novel mechanisms of pathogenesis of Alzheimer’s disease and related dementias.
Potential topics include, but are not limited to:
- Beta-amyloid (Aβ) and tau pathology
- Neuronal death and synaptic dysfunction
- Neuroinflammation
- Risk factors: Lifestyle, cardiovascular diseases, and metabolic disorders et al. in the contribution to Alzheimer's dementia and related dementias
- Cerebrovascular dysfunction, blood–brain barrier leakage, cerebral blood flow dysregulation, neurovascular coupling, cerebrovascular remodeling et al. in Alzheimer's and related dementias
- Immune system in the pathogenesis of Alzheimer's disease and related dementias
- Novel therapies for the treatment of Alzheimer's disease and related dementias.
Dr. Shaoxun Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. NeuroSci is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
